Lv1
66 积分 2024-11-11 加入
Belimumab reduces autoantibodies, normalizes low complement levels, and reduces select B cell populations in patients with systemic lupus erythematosus
1天前
待确认
A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus
1天前
已完结
Effectiveness and Continuous 2‐Week Dosing of Ixekizumab in Practice: A Multicenter Study
16天前
已完结
Higher body weight in Chinese patients is associated with treatment resistance to fixed-dose interleukin-17 inhibition with ixekizumab but not to weight-adjusted secukinumab therapy
17天前
已完结
Mechanistic insights into B-cell activation and autoreactivity regulation in active SLE and remission
24天前
已关闭
Long-term steroid-sparing effect of belimumab in systemic lupus erythematosus: Post hoc pooled analysis of OBSErve multi-country cohort data
25天前
已完结
Safety profile, pharmacokinetics, and biologic activity of MEDI-563, an anti–IL-5 receptor α antibody, in a phase I study of subjects with mild asthma
28天前
已完结
Regulatory eosinophils induce the resolution of experimental arthritis and appear in remission state of human rheumatoid arthritis
30天前
已完结
Benralizumab: from tissue distribution to eosinophilic cytotoxicity up to potential immunoregulation
30天前
已完结
皖公网安备34019202002308
